D-G23
D-G23 is a selective RAD52 inhibitor. D-G23 disrupts RAD52-mediated DNA repair pathways and suppresses the growth of BRCA1- and BRCA2-deficient cancer cells. D-G23 is promising for research of homologous recombination-related cancers, such as hereditary breast cancer and ovarian cancer caused by BRCA1/2 mutations[1].
Product Specifications
CAS Number
1225141-73-0
UNSPSC
12352005
Target
RAD51
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
OCCCNC1=C2C=CC=CC2=NC(NC3=CC(OC)=CC=C3OC)=N1
Molecular Formula
C19H22N4O3
Molecular Weight
354.40
References & Citations
[1]Huang F, et al. Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors. Nucleic Acids Res. 2016 May 19;44 (9) :4189-99.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV641135 1.0 µg DNA
TFPI2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details 
K0655503 1.0 µg DNA
EEF1AL3 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details